Valeo Pharma
  • About Us
    • Overview
    • Board of Directors
    • Executive Team
  • Product Portfolio
    • Respiratory / Allergy
    • Ophthalmology
    • Specialty Products
    • Neurology
    • Oncology
  • Partnering
  • Investors
    • Investor Relations
    • Stock information
    • Corporate Presentation
    • Financial Reports
    • Newsroom
    • Webcasts / Events
    • SEDAR documents
  • Careers
  • Contact
  • Français
Select Page

Financial Reports

2024

Q1  |  Q2  |  Q3

2023

Q1  |  Q2  |  Q3

  • Annual Report
  • Management Information Circular

2022

Q1  |  Q2 |  Q3

  • Annual Report
  • Annual Information Form
  • Management Information Circular

2021

Q1  |  Q2 |  Q3

  • Annual Report
  • Annual Information Form
  • Management Information Circular

2020

Q1 | Q2 | Q3

  • Annual Report
  • Annual Information Form
  • Management Information Circular

2019

Q1  | Q2 | Q3

  • Annual Report
  • Annual Information Form
  • Management Information Circular

2018

  • Annual Report
  • Annual Information Form
  • Management Information Circular

Stay in the loop

I consent to receive news, updates and special offers from Valeo Pharma and it’s affiliates.

Contact us

1-855-694-0151
info@valeopharma.com
16667 Hymus Blvd.
Kirkland, QC H9H 4R9

  • About Us
  • Board of Directors
  • Management Team
  • Careers
  • Our Products
  • Business Development
  • Investors Overview
  • Newsroom
  • Stock Information
  • Financial Reports
  • Contact Us
  • Français

© 2024 Valeo Pharma. All rights reserved.

Speak to a professional

I want to speak to:

15 + 14 =